IL60036A0 - Pharmaceutical compositions comprising an antithrombotic combination - Google Patents

Pharmaceutical compositions comprising an antithrombotic combination

Info

Publication number
IL60036A0
IL60036A0 IL60036A IL6003680A IL60036A0 IL 60036 A0 IL60036 A0 IL 60036A0 IL 60036 A IL60036 A IL 60036A IL 6003680 A IL6003680 A IL 6003680A IL 60036 A0 IL60036 A0 IL 60036A0
Authority
IL
Israel
Prior art keywords
antithrombotic
combination
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL60036A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of IL60036A0 publication Critical patent/IL60036A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL60036A 1979-05-11 1980-05-09 Pharmaceutical compositions comprising an antithrombotic combination IL60036A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH441579 1979-05-11

Publications (1)

Publication Number Publication Date
IL60036A0 true IL60036A0 (en) 1980-07-31

Family

ID=4275714

Family Applications (1)

Application Number Title Priority Date Filing Date
IL60036A IL60036A0 (en) 1979-05-11 1980-05-09 Pharmaceutical compositions comprising an antithrombotic combination

Country Status (5)

Country Link
EP (1) EP0019586A1 (xx)
JP (1) JPS55151512A (xx)
AU (1) AU5828180A (xx)
IL (1) IL60036A0 (xx)
ZA (1) ZA802788B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
WO2006041119A1 (ja) * 2004-10-13 2006-04-20 Eisai R & D Management Co., Ltd. ヒドラジド誘導体
DE602007011231D1 (de) 2006-03-24 2011-01-27 Eisai R&D Man Co Ltd Triazolonderivat
JPWO2009038157A1 (ja) 2007-09-21 2011-01-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 ２，３−ジヒドロ−イミノイソインドール誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2023415C3 (de) * 1970-05-13 1974-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz (beta-Phenylsulfinyl-äthyl) -malonsaure-NjNMiphenylhydrazid und dessen Salze, Verfahren zu dessen Herstellung und diese enthaltende Arzneimittel
US3966923A (en) * 1972-06-05 1976-06-29 Pierre Fabre S.A. Medicaments intended for the prevention and treatment of ischemic disturbances
DE2735830A1 (de) * 1977-08-09 1979-03-01 Thomae Gmbh Dr K Antithrombotische arzneimittelkombination und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
AU5828180A (en) 1980-11-13
EP0019586A1 (de) 1980-11-26
ZA802788B (en) 1981-01-28
JPS55151512A (en) 1980-11-26

Similar Documents

Publication Publication Date Title
AU535604B2 (en) Pharmaceutical compositions
NZ194421A (en) 3-amino-sydnone-imines pharmaceutical compositions
ZA81136B (en) Pharmaceutical compositions
IL56577A (en) Pharmaceutical compositions comprising certain 1-substituted-2-pyrrolidinones
GB2072504B (en) Pharmaceutical compositions
AU535605B2 (en) Pharmaceutical compositions
GB2002230A (en) Antithrombotic pharmaceutical compositions
ZA815700B (en) Pharmaceutical compositions
GB2034587B (en) Pharmaceutical compositions
GB2031727B (en) Pharmaceutical compositions
GB2039218B (en) Pharmaceutical compositions
IL60036A0 (en) Pharmaceutical compositions comprising an antithrombotic combination
AU6501980A (en) Pharmaceutical compositions
NZ193533A (en) 2-isopropylamino-5-halogeno-pyrimidines pharmaceutical compositions
ZA817684B (en) Pharmaceutical compositions
IL60600A (en) Pharmaceutical compositions comprising certain azolylalkenol compounds
ZA794484B (en) Pharmaceutical compositions
SG59387G (en) Pharmaceutical compositions
ZA791032B (en) Pharmaceutical compositions
IL59432A0 (en) Ant-hypertensive pharmaceutical compositions
IL59335A0 (en) Antithrombotic pharmaceutical compositions
GB2049416B (en) Pharmaceutical composition
AU534571B2 (en) Pharmaceutical compositions
IL56716A0 (en) Pharmaceutical compositions comprising certain dibenzodiazzepines
JPS5699415A (en) Medicinal composition